Role of granulocyte colony stimulating factor or human chorionic gonadotropin in improving embryo implantatio
Not Applicable
Completed
- Conditions
- Fertility-female
- Registration Number
- PACTR202006915851110
- Lead Sponsor
- Wald we bent center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
women aged 20-43 years old undergoing ICSI cycles
history of recurrent implantation failure at least 1 cycle in which she had day 5 embryo transfer
Exclusion Criteria
Women with renal sickle cell disease
history of malignancy
history of poor quality embryos
risk of Ovarian hyperstimulation syndrome (OHSS)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie G-CSF and hCG effects on embryo implantation in RIF patients?
How does intra uterine hCG compare to G-CSF in improving implantation rates for recurrent implantation failure?
Which biomarkers correlate with response to G-CSF or hCG in recurrent implantation failure treatment?
What are the safety profiles of G-CSF and hCG in recurrent implantation failure clinical trials?
Are there combination therapies involving G-CSF or hCG that enhance embryo implantation success rates?